Regulacje i polityka gospodarcza · 22/12/1995

FDA Approves Export of SURGISCREEN 0.8 Percent Reagent Red Blood Cells to Multiple Countries

Ortho Diagnostic Systems, Inc. has submitted a request to the FDA for approval to export SURGISCREEN 0.8 percent, Reagent Red Blood Cells to 26 countries in Europe, Australia, and other regions.